This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I):
and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I):
and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I):
and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.